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Long-term hypoglycaemia in patients with an undiagnosed insulinoma is usually associated with severe neurological damage. We report a patient with no neurological deficit despite hypoglycaemia for 26 years due to an insulinoma. Although the presumptive diagnosis of an insulinoma had been made when the patient first presented with hypoglycaemia, surgical excision ofthe tumour was not performed at that time because of difficulty in localizing the insulinoma.
Case report
A 31-year-old woman, eight weeks' pregnant, presented in 1961 with a two month history ofneuroglycopenic symptoms relieved by food. There was no other relevant past history.
Fasting glucose level was 1.6 nmolll and fell to 0.8 nmolll after a 15-h fast with correspondingly elevated levels of serum insulin. Laparotomy was performed when the patient was 20 weeks' pregnant but no tumour was found on inspection of the abdominal contents or after histological examination of the excised tail of the pancreas and the spleen. The islet cells appeared hyperplastic with a histological picture compatible with pregnancy. Fasting hypoglycaernia persisted throughout pregnancy; a normoglycaemic, healthy baby was delivered vaginally at term. The patient was seen a year later; she had continued to have symptoms. She was reinvestigated; hypoglycaemia and hyperinsulinism were present as before. Prednisolone was prescribed on a 'temporary' basis. Thereafter she was lost to follow-up.
In 1977 she was again referred with recurrent hypoglycaemia, having taken prednisolone 10 mg daily for the previous 15 years. Investigation showed a plasma glucose of only 2.1 nmolll after a 24-h fast with a corresponding serum insulin of 12 mU/ml. There were some non-specific changes on the electroencephalogram but no neurological deficit was apparent. Plasma cortisol 24 h after 10 mg prednisolone was 50 nmolll and did not rise after an intramuscular injection of 250 mg tetracosactrin. There were no adrenal antibodies. Abdominal ultrasound examination and coeliac and mesenteric arteriography showed no evidence of a tumour. Prednisolone was continued because of the adrenal suppression but she did not attend hospital again until 1980 when she was referred once again with recurrent hypoglycaemic symptoms. No tumour was seen on CT scan of the abdomen. After intravenous insulin (0.15 Ulkg) plasma glucose fell from 2.2 nmolll to 0.6 nmolll; correspondingly, serum C-peptide was 1.45 ng/ml initially and did not fall during insulin induced hypoglycaemia. At this stage the patient refused further investigation. Diazoxide 100 mg daily together with chlorothiazide 500 mg daily was therefore prescribed. Prednisolone was continued in a dose of 8 mg daily because of adrenal suppression after prolonged steroid therapy.
She failed to attend hospital on a regular basis but remained well until 1987 when she was admitted because of an adrenal crisis with hypoglycaemic symptoms associated with a urinary tract infection. There were no abnormal neurological signs; antibiotics and corticosteroids were given. Investigation again revealed a low fasting glucose level of 2.4 nmolll with an inappropriate serum insulin of 11 mUlml. No tumour was seen on ultrasound or CT scanning of the abdomen; the adrenals were not visualized and were thought to be atrophic.
The patient finally agreed to further investigation. Mesenteric and coeliac arteriography showed no tumour but after selective venous sampling along the portal, splenic and superior mesenteric veins, an area of increased insulin concentration was identified near the body of the pancreas. At laparotomy, a tumour 8 mm in diameter was identified in the region of the 'hot' spot and excised. Histology confirmed an insulinoma. Postoperatively, she has remained asymptomatic on maintenance hydrocortisone in physiological doses.
Discussion
There are a number of interesting features in this woman's history. Firstly, unlike other patients with long-term hypoglycaemia'P, the diagnosis of an insulinoma was made at the time of her initial presentation in 1961 when Case presented to Section of Endocrinology, 28 October 1987 0141-0768189/ 070437-021$02.00/0. ©1989 The Royal Society of Medicine measurement of plasma insulin by radioimmunoassay was in its infancy. Indeed, the 1961 measurements were made by Ellis Samols who had just brought the new assay technique back from the pioneers of radioimmunoassay, Rosalyn Yalow and Sam Berson". Secondly, the tumour was not apparent at the first laparotomy and was only located 26 years later when selective venous sampling identified the area of insulin hypersecretion. We would like to stress the importance of selective venous sampling because the need for preoperative localization of insulinomata has been questioned and it has been suggested that exploratory laparotomy is the investigation of choice", However, as illustrated in this case, the tumour may not be seen at laparotomy, particularly if it is small, and even arteriography may fail to localize a small tumour. Hence, we maintain, if conventional radiological techniques fail to localize a tumour the next investigation should be selective venous sampling, and not surgery.
The absence of any neurological deficit in this patient is also remarkable and contrasts with previous case reports. We attribute this to the medical therapy which prevented serious hypoglycaemia during the 26 years preceding removal of the insulinoma. Although no data is available about the long-term use of either prednisolone or diazoxide in this condition, we suggest that the continued predniso- We report a case of adult linear IgA dermatosis in association with hydatidiform mole, with unusual clinical and immunological features.
Case report
A 24-year-old woman had a hydatidiform mole excised in her third pregnancy in 1984. At this time she noted an intermittent blistering eruption over the trunk, legs and face. Episodes of blistering persisted for several weeks at a time, but were insufficiently symptomatic to require referral to a dermatologist. Her condition worsened in 1986, however. necessitating hospital referral. Examination revealed extensive areas of tense fluid filled olistering over trunk, lower limbs and face. At this time a biopsy oflesional skin demonstrated a subepidermal bulla with spongiosis and a mixed inflammatory infiltrate.
Immunofluorescence of'perilesional skin showed a linear band of IgA in the basement membrane zone. Treatment was commenced with dapsone 50 mg twice a day with good disease control. Six months after this treatment was instigated she developed haemolysis and macrocytosis related to dapsone which was therefore changed to sulphamethoxypyridazine 500 mg twice a day. On this regime she has remained reasonably well controlled but still has intermittent episodes of blistering, particularly around the nose and on the lower limbs. Recent ophthalmological examination has revealed unusual fine linear conjunctival scarring on the tarsal surface of both lower lids (Figure 1 ). lone kept the blood glucose at a reasonable level by virtue of its gluconeogenic effects. We also wonder if the prednisolone may have been a factor limiting growth of the tumour.
The two lessons from this report are that an insulinoma can be controlled medically for decades without the development of neurological complications and that small tumours may be missed at laparotomy. Preoperative localization of a tumour, if necessary by selective venous sampling, is therefore essential if an insulinoma is suspected on clinical and biochemical grounds and cannot be located by ultrasound or CT scanning. 
